Bulk Manufacturer of Controlled Substances Application: Purisys, LLC, 53009 [2022-18739]
Download as PDF
<![CDATA[
53009
khammond on DSKJM1Z7X2PROD with NOTICES
Federal Register / Vol. 87, No. 167 / Tuesday, August 30, 2022 / Notices
VA; Vana Solutions, LLC., Beavercreek,
OH; VG IT Services, Inc., Ashburn, VA;
and W5 Technologies, Inc., Scottsdale,
AZ have been added as parties to this
venture.
Also, 1901 Group LLC, Reston, VA;
Alteryx, Inc., Irvine, CA; Aptima, Inc.,
Woburn, MA; Assured Wireless Corp.,
San Diego, CA; AT&T Government
Solutions, Inc., Vienna, VA; Broadband
Antenna Tracking Systems, Inc.,
Indianapolis, IN; Clemson University,
Clemson, SC; Decisive Analytics Corp.,
Arlington, VA; Dover Microsystems,
Inc., Waltham, MA; EPS Corp., Tinton
Falls, NJ; Global Planning Initiatives
LLC, Virginia Beach, VA;
HigherEchelon, Inc., Huntsville, AL;
Inonde, McLean, VA; IT Partners, Inc.,
Herndon, VA; KNC Strategic Services,
Oceanside, CA; Kopis Mobile LLC,
Flowood, MS; Kudu Dynamics LLC,
Chantilly, VA; L3Harris Technologies,
Palm Bay, FL; Lexington Solutions
Group LLC, Lexington, VA; Motorola
Solutions, Inc. US Federal Markets
Division, Linthicum, MD; NewSat North
America LLC, Indian Harbour Beach,
FL; Nobletech Solutions, Huntsville,
AL; Poplicus, Inc. dba Govini,
Arlington, VA; ProSync Technology
Group, Ellicott City, MD; Rincon
Research Corp., Tucson, AZ;
SafeFlights, Inc. dba 14bis Supply
Tracking, Burlington, MA; Shield AI,
Inc., San Diego, CA; Shift5, Inc.,
Rosslyn, VA; Si2 Technologies, Inc.,
North Billerica, MA; Southern
Methodist University, Dallas, TX; Streif
Enterprise, Inc. dba ibeeto, El Cajon, CA;
Taurean General Services, Boerne, TX;
XATOR Corp., Reston, VA; and XR 2
LEAD LLC, Dumfries VA have
withdrawn from this venture.
No other changes have been made in
either the membership or planned
activity of the group research project.
Membership in this group research
project remains open, and IWRP intends
to file additional written notifications
disclosing all changes in membership.
On October 15, 2018, IWRP filed its
original notification pursuant to section
6(a) of the Act. The Department of
Justice published a notice in the Federal
Register pursuant to section 6(b) of the
Act on October 23, 2018 (83 FR 53499).
The last notification was filed with
the Department on April 6, 2022. A
notice was published in the Federal
Register pursuant to section 6(b) of the
Act on May 13, 2022 (87 FR 29385).
Suzanne Morris,
Chief, Premerger and Division Statistics
Antitrust Division.
[FR Doc. 2022–18695 Filed 8–29–22; 8:45 am]
BILLING CODE P
VerDate Sep<11>2014
17:24 Aug 29, 2022
Jkt 256001
DEPARTMENT OF JUSTICE
Drug
code
Controlled substance
Schedule
Drug Enforcement Administration
Meperidine intermediate-C.
[Docket No. DEA–1061]
Bulk Manufacturer of Controlled
Substances Application: Purisys, LLC
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Purisys, LLC, has applied to
be registered as a bulk manufacturer of
basic class(es) of controlled
substance(s). Refer to Supplementary
Information listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 31, 2022. Such
persons may also file a written request
for a hearing on the application on or
before October 31, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
is notice that on June 6, 2022, Purisys,
LLC, 1550 Olympic Drive, Athens,
Georgia 30601–1602, applied to be
registered as a bulk manufacturer of the
following basic class(es) of controlled
substance(s):
SUMMARY:
Controlled substance
Ibogaine ........................
5-Methyoxy-N,Ndiisopropyltryptamine.
Cocaine ........................
Ecgonine .......................
Meperidine ....................
Meperidine intermediate-A.
Meperidine intermediate-B.
PO 00000
Frm 00109
Fmt 4703
Drug
code
Schedule
7260
7439
I
I
9041
9180
9230
9232
II
II
II
II
9233
II
Sfmt 4703
9234
I
II
I
The company plans to bulk
manufacture the listed controlled
substances for the production of active
pharmaceutical ingredients (API) and
analytical reference standards for sale to
its customers. The company plans to
manufacture the above listed controlled
substances as clinical trial and starting
materials to make compounds for
distribution to its customers. No other
activities for these drug codes are
authorized for this registration.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–18739 Filed 8–29–22; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1069]
Importer of Controlled Substances
Application: Caligor Coghlan Pharma
Services
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Caligor Coghlan Pharma
Services has applied to be registered as
an importer of basic class(es) of
controlled substance(s). Refer to
Supplementary Information listed below
for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before September 29, 2022. Such
persons may also file a written request
for a hearing on the application on or
before September 29, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
SUMMARY:
E:\FR\FM\30AUN1.SGM
30AUN1
]]>Agencies
[Federal Register Volume 87, Number 167 (Tuesday, August 30, 2022)]
[Notices]
[Page 53009]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18739]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1061]
Bulk Manufacturer of Controlled Substances Application: Purisys,
LLC
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Purisys, LLC, has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
Supplementary Information listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
October 31, 2022. Such persons may also file a written request for a
hearing on the application on or before October 31, 2022.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on June 6, 2022, Purisys, LLC, 1550 Olympic Drive,
Athens, Georgia 30601-1602, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Ibogaine............................... 7260 I
5-Methyoxy-N,N-diisopropyltryptamine... 7439 I
Cocaine................................ 9041 II
Ecgonine............................... 9180 II
Meperidine............................. 9230 II
Meperidine intermediate-A.............. 9232 II
Meperidine intermediate-B.............. 9233 II
Meperidine intermediate-C.............. 9234 II
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for the production of active pharmaceutical ingredients
(API) and analytical reference standards for sale to its customers. The
company plans to manufacture the above listed controlled substances as
clinical trial and starting materials to make compounds for
distribution to its customers. No other activities for these drug codes
are authorized for this registration.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-18739 Filed 8-29-22; 8:45 am]
BILLING CODE 4410-09-P
